Injectable Drug Delivery Market Size to Reach USD 1,235.53 Billion in 2027 | Industry Trend – Rapid Advancements in Injectable Drug Delivery Technology

Increasing preference for self-injection devices, rising demand for biologics and increasing investments in research and development activities are some key factors expected to fuel market growth

Emergen Research has published its latest report titled, “Injectable Drug Delivery Market By Product Type (Formulations, Devices), By Therapeutic Application (Hormonal disorders, Autoimmune disorders, Oncology, Others), By End Use (Homecare settings, Hospitals & Clinics, Others), and By Region, Forecasts to 2027”

According to Emergen Research, the global injectable drug delivery market size was USD 525.37 billion in 2019 and is expected to reach USD 1,235.53 billion in 2027 and register a revenue CAGR of 11.3% during the forecast period, 2020-2027.

Market Dynamics: 

Drug delivery refers to the technology of delivering drugs or pharmaceuticals to the desired site of the body for drug release and absorption. Injectable drug delivery enables faster drug delivery as compared to pills, capsules, and tablets. It comprises auto-injectors, pen injectors, needle-free injectors, and conventional syringes and is widely used for treating hormonal imbalances, autoimmune diseases, hemophilia, and hepatitis among others. Market revenue growth is significantly driven by rising prevalence of various infectious and chronic diseases, increasing geriatric population, and increasing demand for self-injection devices and home care settings. 

Click Here to Access Free sample PDF Copy of the Report@ https://www.emergenresearch.com/request-sample/112

Other factors such as increasing demand for convenient and effective drug delivery, high adoption of innovative injectable drug delivery technologies, presence of key manufacturers, and increasing awareness about injectable drug delivery technology are expected to fuel market growth during the forecast period. In addition, high risk of needle sticks injuries, rising demand for wearable insulin pumps, and increasing investments for developing advanced, patient-friendly injectable drug delivery systems are expected to fuel market growth going ahead. However, high cost of advanced injectable products, high preference for traditional injectable products especially in developing countries, and lack of adequate reimbursement scenarios are some key factors expected to hamper market growth to a certain extent over the forecast period. 

COVID-19 Impact Analysis 

  • Social distancing and restrictions severely disrupted businesses and operations
  • Lockdowns caused disruptions in transportation and logistics
  • Impacted manufacturing activities and mining operations globally
  • Took a toll on economy of various countries
  • Caused sudden and drastic downturn in economic activity
  • Disrupted agriculture, fisheries, dairy, and other sectors
  • Caused loss of employment and financial crisis
  • Supply impacts were further compounded owing to reduced disposable income
  • Emergence of variants continue to cause concerns and impact normal routines

Formulation Segment to Register Steady Revenue Growth: 

The formulation segment is expected to register steady revenue growth during the forecast period owing to increasing prevalence of chronic diseases, rising investments for developing advanced drug injectables, and availability of a wide range of formulations including solutions, suspensions, lyophilized formulations, and colloidal dispersions. 

Hospital Segment to Account for Largest Revenue Share:

The hospital segment is expected to account for largest revenue share over the forecast period owing to increasing patient pool across the globe, increasing hospital stays, availability of advanced injectable medicines, and presence of highly skilled healthcare professionals.

Looking for Discount [Click on the link] @ https://www.emergenresearch.com/request-discount/112

North America to Dominate Other Regions in Terms of Revenue Share: 

North America is expected to account for largest revenue share in the global market over the forecast period attributable to factors such as increasing prevalence of diabetes, cancer, and other chronic diseases across the region, rising demand for self-injection devices, and increasing awareness about chronic diseases. Other factors such as high healthcare spending, presence of leading key players, and increasing investments in research and development activities are expected to fuel North America market growth going ahead.

Major Companies in the Market Include:

  • Terumo Corporation
  • Eli Lilly and Company
  • Becton, Dickson and Company
  • Pfizer, Inc.
  • Baxter International, Inc.
  • Schott AG
  • Bespak
  • Elcam Medical
  • Gerresheimer Ag
  • Sandoz

For the purpose of this report, Emergen Research has segmented the global injectable drug delivery market on the basis of product type, therapeutic application, end-user, and region:

Product Type Outlook (Revenue, USD Billion; 2017-2027)

  • Formulations
  • Devices

Therapeutic Application Outlook (Revenue, USD Billion; 2017-2027)

  • Hormonal disorders
  • Autoimmune disorders
  • Oncology
  • Others

End Use Outlook (Revenue, USD Billion; 2017-2027)

  • Homecare settings
  • Hospitals & Clinics
  • Others

Have a look at Report Description and Table of Contents of Market Report@ https://www.emergenresearch.com/industry-report/injectable-drug-delivery-market

Regional Outlook (Revenue, USD Billion; 2017–2027)

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • U.K.
    • BENELUX
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of APAC
  • Latin America
    • Brazil
    • Rest of LATAM
  • Middle East & Africa
    • Saudi Arabia
    • U.A.E.
    • South Africa
    • Turkey
    • Rest of MEA

Explore Similar Reports offered by Emergen Research:

Air Purifier Market By Technology (HEPA, Activated Carbon, Ionic Filters, Others), By Applications (Commercial, Residential, Industrial, Others) and By Regions Forecasts to 2027.

Nanocoatings Market By Product Type (Antimicrobial, Anti-Fouling & Easy-to-Clean, Self-Cleaning. Anti-Fingerprints), By Distribution Channel, By Industry Verticals (Healthcare, Automotive, Building & Construction, Electronics, Marine, Energy, Water Treatment, Packaging), Forecasts to 2027.

Metamaterials Market By Product Type (Electromagnetic, Tunable, Photonic, Frequency Selective Surface, Terahertz), By Application (Absorber, Antenna, Cloaking Devices, Super Lens, MRI, X-ray), By End Use (Medical, Automotive, Consumer Electronics, Aerospace & Defense, Energy & Power) and Regions Forecasts to 2027

Metal Foam Market By Material (Aluminum, Copper, Titanium, Zinc, Nickel), By Product (Open Cell, Closed Cell), By Application (Floating Cities, Heat Exchangers, Anti-Intrusion Bars, Energy Absorbers), By End-Use, and By Region Forecast to 2028.

Fullerene Market By Type (C60, C70, C76, Other), By Production Method (Arc Discharge Method, CVD/CCVD Process, Laser Ablation of Graphite, Others), By Shape (Nanotubes, Bucky Balls, Nano-Rods), By End-use, and By Region Forecast to 2028.

Amorphous Metals Market, By Type (Iron Based, Cobalt Based, Others), By Process (Chemical Process, Physical Process), By Application, By End-use, and By Region Forecast to 2028.

About Emergen Research

Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

Contact Us:

Eric Lee

Corporate Sales Specialist

Emergen Research | Web: www.emergenresearch.com

Direct Line: +1 (604) 757-9756

E-mail: sales@emergenresearch.com

Visit for More Insights: https://www.emergenresearch.com/insights

Explore Our Custom Intelligence services | Growth Consulting Services

Read Our Press Release@ https://www.emergenresearch.com/press-release/global-injectable-drug-delivery-market

 

 

 

 

 

 

 

Back to news